Comparison of the proteome patterns of adipose-derived stem cells with those treated with selegiline using a two dimensional gel electrophoresis analysis

References

• Abdanipour A, Tiraihi T. 2012. Induction of adipose-derived stem cell into motoneuron-like cells using selegiline as preinducer. Brain Res. 1440:23–33. doi:10.1016/j.brainres.2011.12.051.
   PubMed Web of Science ®Google Scholar
• Abdanipour A, Tiraihi T, Delshad AR. 2011. Trans-differentiation of the adipose tissue-derived stem cells into neuron-like cells expressing neurotrophins by selegiline. Iran Biomed J. 15:113–121.
   PubMedGoogle Scholar
• Alberch J, Perez-Navarro E, Canals J. 2002. Neuroprotection by neurotrophins and Gdnf family members in the excitotoxic model of Huntington’s disease. Brain Res Bull. 57:817–822. doi:10.1016/s0361-9230(01)00775-4.
   PubMed Web of Science ®Google Scholar
• Balasubramanian A. 2002. Unusual catalytic activities and functions of cholinesterases. Ind J Biochem Biophys. 39:77–81.
   PubMed Web of Science ®Google Scholar
• Baloh RH, Tansey MG, Golden JP, Creedon DJ, Heuckeroth RO, Keck CL, Zimonjic DB, Popescu NC, Johnson EM Jr, Milbrandt J. 1997. Trnr2, a novel receptor that mediates neurturin and Gdnf signaling through Ret. Neuron. 18:793–802.
   PubMed Web of Science ®Google Scholar
• Birkmayer W, Riederer P, Youdim M, Linauer W. 1975. The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of Mao-B, deprenil. J Neur Trans. 36:303–326. doi:10.1007/BF01253131.
   Google Scholar
• Bradford M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254. doi:10.1006/abio.1976.9999.
   PubMed Web of Science ®Google Scholar
• Brimijoin S, Koenigsberger C. 1999. Cholinesterases in neural development: new findings and toxicologic implications. Env Health Perspec. 107:59–64.
   PubMed Web of Science ®Google Scholar
• Candiano G, Bruschi M, Musante L, Santucci L, Ghiggeri GM, Carnemolla B, Orecchia P, Zardi L, Righetti PG. 2004. Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis. 25:1327–1333. doi:10.1002/elps.200305844.
   PubMed Web of Science ®Google Scholar
• Cass WA, Peters LE, Harned ME, Seroogy KB. 2006. Protection by Gdnf and other trophic factors against the dopamine‐depleting effects of neurotoxic doses of methamphetamine. Ann NY Acad Sci. 1074:272–281. doi:10.1196/annals.1369.024.
   PubMed Web of Science ®Google Scholar
• Chen Y, Tian Q. 2011. The role of protein kinase C epsilon in neural signal transduction and neurogenic diseases. Front Med. 5:70–76. doi:10.1007/s11684-011-0119-9.
   PubMedGoogle Scholar
• Corbit KC, Soh J-W, Yoshida K, Eves EM, Weinstein IB, Rosner MR. 2000. Different protein kinase C isoforms determine growth factor specificity in neuronal cells. Mol Cell Biol. 20:5392–5403. doi:10.1128/mcb.20.15.5392-5403.2000.
   PubMed Web of Science ®Google Scholar
• Darvishi M, Tiraihi T, Mesbah-Namin SA, Delshad A, Taheri T. 2017. Motor neuron transdifferentiation of neural stem cell from adipose-derived stem cell characterized by differential gene expression. Cell Mol Neurobiol. 37:275–289. doi:10.1007/s10571-016-0368-x.
   PubMed Web of Science ®Google Scholar
• Esmaeili F, Tiraihi T, Movahedin M, Mowla SJ. 2006. Selegiline induces neuronal phenotype and neurotrophins expression in embryonic stem cells. Rejuv Res. 9:475–484. doi:10.1089/rej.2006.9.475.
   PubMed Web of Science ®Google Scholar
• Ghorbanian MT, Tiraihi T, Mesbah-Namin SA, Fathollahi Y. 2010. Selegiline is an efficient and potent inducer for bone marrow stromal cell differentiation into neuronal phenotype. Neurol Res. 32:185–193. doi:10.1179/174313209X409016.
   PubMed Web of Science ®Google Scholar
• Guo P, Sun H, Zhang Y, Tighe S, Chen S, Su CW, Liu Y, Zhao H, Hu M, Zhu Y. 2018. Limbal niche cells are a potent resource of adult mesenchymal progenitors. J Cell Mol Med. 2018 Jul;22(7):3315–3322.
   PubMed Web of Science ®Google Scholar
• Gyárfás T, Knuuttila J, Lindholm P, Rantamäki T, Castrén E. 2010. Regulation of brain-derived neurotrophic factor (Bdnf) and cerebral dopamine neurotrophic factor (Cdnf) by anti-Parkinsonian drug therapy in vivo. Cell Mol Neurobiol. 30:361–368. doi:10.1007/s10571-009-9458-3.
   PubMed Web of Science ®Google Scholar
• Harada C, Harada T, Quah H-M, Maekawa F, Yoshida K, Ohno S, Wada K, Parada L, Tanaka K. 2003. Potential role of glial cell line-derived neurotrophic factor receptors in Müller glial cells during light-induced retinal degeneration. Neuroscience. 122:229–235. doi:10.1016/s0306-4522(03)00599-2.
   PubMed Web of Science ®Google Scholar
• Hishiki T, Nimura Y, Isogai E, Kondo K, Ichimiya S, Nakamura Y, Ozaki T, Sakiyama S, Hirose M, Seki N. 1998. Glial cell line-derived neurotrophic factor/neurturin-induced differentiation and its enhancement by retinoic acid in primary human neuroblastomas expressing C-Ret, Gfrα-1, and Gfrα-2. Cancer Res. 58:2158–2165.
   PubMed Web of Science ®Google Scholar
• Huang K-P. 1989. The mechanism of protein kinase C activation. Trends Neurosci. 12:425–432.
   PubMed Web of Science ®Google Scholar
• Igarashi Y, Chiba H, Utsumi H, Miyajima H, Ishizaki T, Gotoh T, Kuwahara K, Tobioka H, Satoh M, Mori M. 2000. Expression of receptors for glial cell line-derived neurotrophic factor (Gdnf) and neurturin in the inner blood-retinal barrier of rats. Cell Struct Func. 25:237–241. doi:10.1247/csf.25.237.
   PubMed Web of Science ®Google Scholar
• Ikemoto T, Feng R, Shimada M, Saito Y, Iwahashi S, Morine Y, Imura S. 2018. A new 2-step acceleration protocol using a histone deacetylase inhibitor to generate insulin-producing cells from adipose-derived mesenchymal stem cells. Pancreas. 47:477–481. doi:10.1097/MPA.0000000000001017.
   PubMed Web of Science ®Google Scholar
• Jing S, Yu Y, Fang M, Hu Z, Holst PL, Boone T, Delaney J, Schultz H, Zhou R, Fox GM. 1997. Gfrα-2 and Gfrα-3 are two new receptors for ligands of the gdnf family. J Biol Chem. 272:33111–33117. doi:10.1074/jbc.272.52.33111.
   PubMed Web of Science ®Google Scholar
• Kaplan DR, Matsumoto K, Lucarelli E, Thielet CJ. 1993. Induction of Trkb by retinoic acid mediates biologic responsiveness to Bdnf and differentiation of human neuroblastoma cells. Neuron. 11:321–331.
   PubMed Web of Science ®Google Scholar
• Knudsen Gerber D. 2011. Selegiline and rasagiline: twins or distant cousins? Guidelines. Consult Pharm. 26:48–51. doi:10.4140/TCP.n.2011.48.
   PubMedGoogle Scholar
• Knull J. 1998. (‐) Deprenyl (selegiline), a catecholaminergic activity enhancer (Cae) substance acting in the brain. Pharmacol Toxicol. 82:57–66.
   PubMedGoogle Scholar
• Konno M, Hamabe A, Hasegawa S, Ogawa H, Fukusumi T, Nishikawa S, Ohta K, Kano Y, Ozaki M, Noguchi Y. 2013. Adipose‐derived mesenchymal stem cells and regenerative medicine. Dev Growth Differ. 55:309–318. doi:10.1111/dgd.12049.
   PubMed Web of Science ®Google Scholar
• Kozlowski LP. 2017. Proteome-pi: proteome isoelectric point database. Nucl Acids Res. 45:D1112–D1116. doi:10.1093/nar/gkw978.
   PubMed Web of Science ®Google Scholar
• Mack A, Robitzki A. 2000. The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense-5′ butyrylcholinesterase-DNA study. Prog Neurobiol. 60:607–628.
   PubMed Web of Science ®Google Scholar
• Marsh SE, Blurton-Jones M. 2017. Neural stem cell therapy for neurodegenerative disorders: the role of neurotrophic support. Neurochem Int. 106:94–100. doi:10.1016/j.neuint.2017.02.006.
   PubMed Web of Science ®Google Scholar
• Meliga E, Strem BM, Duckers H, Serruys PW. 2007. Adipose-derived cells. Cell Transplant. 16:963–970. doi:10.3727/096368907783338190.
   PubMed Web of Science ®Google Scholar
• Miloso M, Scuteri A, Foudah D, Tredici G. 2008. Mapks as mediators of cell fate determination: an approach to neurodegenerative diseases. Curr Med Chem. 15:538–548.
   PubMed Web of Science ®Google Scholar
• Mimeault M, Hauke R, Batra SK. 2007. Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther. 82:252–264. doi:10.1038/sj.clpt.6100301.
   PubMed Web of Science ®Google Scholar
• Mizuta I, Ohta M, Ohta K, Nishimura M, Mizuta E, Hayashi K, Kuno S. 2000. Selegiline and desmethylselegiline stimulate Ngf, Bdnf, and Gdnf synthesis in cultured mouse astrocytes. Biochem Biophys Res Commun. 279:751–755. doi:10.1006/bbrc.2000.4037.
   PubMed Web of Science ®Google Scholar
• Nakagami H, Morishita R, Maeda K, Kikuchi Y, Ogihara T, Kaneda Y. 2006. Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. J Atheroscler Thromb. 13:77–81. doi:10.5551/jat.13.77.
   PubMed Web of Science ®Google Scholar
• Neradil J, Veselska R. 2015. Nestin as a marker of cancer stem cells. Cancer Sci. 106:803–811. doi:10.1111/cas.12691.
   PubMed Web of Science ®Google Scholar
• Oehrlein SA, Maelicke A, Herget T. 1998. Expression of protein kinase C gene family members is temporally and spatially regulated during neural development in vitro. Eur J Cell Biol. 77:323–337. doi:10.1016/S0171-9335(98)80091-5.
   PubMed Web of Science ®Google Scholar
• Oiwa Y, Yoshimura R, Nakai K, Itakura T. 2002. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson’s disease. Brain Res. 947:271–283. doi:10.1016/s0006-8993(02)02934-7.
   PubMed Web of Science ®Google Scholar
• Ramaswamy S, Kordower JH. 2009. Are growth factors the answer? Parkinsonism Relat Disord. 15:S176–S180. doi:10.1016/S1353-8020(09)70809-0.
   PubMedGoogle Scholar
• Rolletschek A, Chang H, Guan K, Czyz J, Meyer M, Wobus AM. 2001. Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promoting factors. Mech Dev. 105:93–104.
   PubMed Web of Science ®Google Scholar
• Semkova I, Wolz P, Schilling M, Krieglstein J. 1996. Selegiline enhances Ngf synthesis and protects central nervous system neurons from excitotoxic and ischemic damage. Eur J Pharmacol. 315:19–30. doi:10.1016/s0014-2999(96)00593-6.
   PubMed Web of Science ®Google Scholar
• Shirazi HA, Rasouli J, Ciric B, Rostami A, Zhang G-X. 2015. 1, 25-Dihydroxyvitamin D3 enhances neural stem cell proliferation and oligodendrocyte differentiation. Exp Mol Pathol. 98:240–245. doi:10.1016/j.yexmp.2015.02.004.
   PubMed Web of Science ®Google Scholar
• Tang YP, Ma YL, Chao CC, Chen KY, Lee EH. 1998. Enhanced glial cell line‐derived neurotrophic factor Mrna expression upon (−)‐deprenyl and melatonin treatments. J Neurosci Res. 53:593–604. doi:10.1002/(SICI)1097-4547(19980901)53:5<593::AID-JNR9>3.0.CO;2-4.
   PubMed Web of Science ®Google Scholar
• Tatton W, Chalmers-Redman R, Ju W, Mammen M, Carlile G, Pong A, Tatton N. 2002. Propargylamines induce antiapoptotic new protein synthesis in serum-and nerve growth factor (Ngf)-withdrawn, Ngf-differentiated Pc-12 cells. J Pharmacol Exp Ther. 301:753–764.
   PubMed Web of Science ®Google Scholar
• Tiethof A, Richardson J, Hart R. 2018. Knockdown of butyrylcholinesterase but not inhibition by chlorpyrifos alters early differentiation mechanisms in human neural stem cells. Toxics. 6:52–65. doi:10.3390/toxics6030052.
   Web of Science ®Google Scholar
• UniProt Consortium T. 2018. Uniprot: the universal protein knowledge base. Nucl Acids Res. 46:2699. doi:10.1093/nar/gky092.
   PubMed Web of Science ®Google Scholar
• Vogel-Hopker A, E Sperling L, G Layer P. 2012. Co-opting functions of cholinesterases in neural, limb and stem cell development. Prot Pept Lett. 19:155–164. doi:10.2174/092986612799080266.
   PubMed Web of Science ®Google Scholar
• Wan Safwani WKZ, Makpol S, Sathapan S, Chua KH. 2011. The changes of stemness biomarkers expression in human adipose‐derived stem cells during long‐term manipulation. Biotechnol Appl Biochem. 58:261–270. doi:10.1002/bab.38.
   PubMed Web of Science ®Google Scholar
• Wang W-P, He Z-L, Lu S-Y, Yan M, Zhou Y, Xie T-H, Yin N, Wang W-J, Tang D-H, H-J L. 2015. Dopaminergic neuron-like cells derived from bone marrow mesenchymal stem cells by Lmx1α and neurturin overexpression for autologous cytotherapy in hemiparkinsonian Rhesus monkeys. Curr Stem Cell Res Ther. 10:109–120.
   PubMed Web of Science ®Google Scholar
• Weinreb O, Amit T, Sagi Y, Drigues N, Youdim MB. 2009. Genomic and proteomic study to survey the mechanism of action of the anti-Parkinson’s disease drug, rasagiline compared with selegiline, in the rat midbrain. J Neur Trans. 116:1457–1472.
   Google Scholar
• Xian CJ, Huang B-R, Zhou X-F. 1999. Distribution of neurturin Mrna and immunoreactivity in the peripheral tissues of adult rats. Brain Res. 835:247–258. doi:10.1016/s0006-8993(99)01590-5.
   PubMed Web of Science ®Google Scholar
• Yan M, Sun M, Zhou Y, Wang W, He Z, Tang D, Lu S, Wang X, Li S, Wang W. 2013. Conversion of human umbilical cord mesenchymal stem cells in Wharton’s jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson’s disease in a Rhesus monkey model. PloS One. 8:e64000. doi:10.1371/journal.pone.0064000.
   PubMed Web of Science ®Google Scholar
• Yang H-Q, Ba M-W, Ren R-J, Zhang Y-H, Ma J-F, Pan J, Lu G-Q, Chen S-D. 2007. Mitogen activated protein kinase and protein kinase C activation mediate promotion of sappα secretion by deprenyl. Neurochem Internat. 50:74–82. doi:10.1016/j.neuint.2006.07.016.
   PubMed Web of Science ®Google Scholar
• Yeh E, Dermer M, Commisso C, Zhou L, McGlade CJ, Boulianne GL. 2001. Neuralized functions as an E3 ubiquitin ligase during Drosophila development. Curr Biol. 11:1675–1679. doi:10.1016/s0960-9822(01)00527-9.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Cai D, Bai Y. 2013. Selegiline rescues gait deficits and the loss of dopaminergic neurons in a subacute Mptp mouse model of Parkinson’s disease. Int J Mol Med. 32:883–891. doi:10.3892/ijmm.2013.1450.
   PubMed Web of Science ®Google Scholar